Title : Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.

Pub. Date : 2020 May 14

PMID : 32187361






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The identification of both good and poor risk subtypes in patients treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) clearly show the clinical value of the approach, confirming the need for a consensus classification. Doxorubicin DNA damage inducible transcript 3 Homo sapiens